Search results
CTI BioPharma Corp. (NASDAQ:CTIC) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoCTI BioPharma Corp. (NASDAQ:CTIC) Q4 2022 Earnings Call Transcript March 6, 2023 Operator: Good...
Will CTI BioPharma (CTIC) Report Negative Earnings Next Week? What You Should Know
Zacks via Yahoo Finance· 1 year agoCTI BioPharma (CTIC) doesn't possess the right combination of the two key ingredients for a likely...
CTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 year agoCTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively,...
Why Shares of CTI BioPharma Are Soaring Wednesday
Motley Fool· 1 year agoWhat happened Shares of CTI BioPharma (NASDAQ: CTIC) were up more than 80% early Wednesday after the company announced it was getting bought out for $1.7...
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
Benzinga via Yahoo Finance· 1 year agoSwedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for...
Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?
Zacks via Yahoo Finance· 1 year agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group...
Why CTI BioPharma Stock Withered on Wednesday
Motley Fool· 2 years agoIn contrast to many other biotechs, CTI stock has done fairly well this year -- in fact, it has nearly doubled since the beginning of this year. This...
Why CTI BioPharma Stock Crushed the Market Today
Motley Fool· 2 years agoThe stock market as a whole had a fine Monday, but CTI BioPharma (NASDAQ: CTIC) had a particularly good time of it. The China-based biotech's shares...
Analyst Thinks This Company's Bone Marrow Cancer Treatment Can 'Transform Paradigm'
Benzinga via Yahoo Finance· 2 years agoSVB Leerink initiated coverage on CTI Biopharma Corp (NASDAQ: CTIC) with an Outperform rating and a...
CTI BioPharma: Q4 Earnings Snapshot
AP Finance via Yahoo Finance· 1 year agoSEATTLE (AP) — SEATTLE (AP) — CTI BioPharma Corp. (CTIC) on Monday reported a loss of $17.5 million in its fourth quarter. On a per-share basis, the Seattle-based company said it had a loss ...
